➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Boehringer Ingelheim
McKesson
Mallinckrodt
Harvard Business School

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

K-TAB Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do K-tab patents expire, and what generic alternatives are available?

K-tab is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in K-TAB is potassium chloride. There are two hundred and forty drug master file entries for this compound. Seventy-six suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.

US ANDA Litigation and Generic Entry Outlook for K-tab

A generic version of K-TAB was approved as potassium chloride by ACTAVIS LABS FL INC on April 10th, 2002.

  Start Trial

US Patents and Regulatory Information for K-TAB

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie K-TAB potassium chloride TABLET, EXTENDED RELEASE;ORAL 018279-002 Aug 1, 1988 BC RX Yes No   Start Trial   Start Trial   Start Trial
Abbvie K-TAB potassium chloride TABLET, EXTENDED RELEASE;ORAL 018279-001 Approved Prior to Jan 1, 1982 AB3 RX Yes No   Start Trial   Start Trial   Start Trial
Abbvie K-TAB potassium chloride TABLET, EXTENDED RELEASE;ORAL 018279-003 Nov 25, 2013 AB3 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Dow
Johnson and Johnson
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.